hypothalamic obesity
Showing 1 - 13 of 13
Hypothalamic Obesity Trial in Gainesville (Setmelanotide, Placebo)
Recruiting
- Hypothalamic Obesity
- Setmelanotide
- Placebo
-
Gainesville, FloridaUniversity of Florida
Mar 16, 2023
Hypothalamic Obesity Trial in Lansing (Placebo, Tesomet)
Suspended
- Hypothalamic Obesity
- Placebo
- Tesomet
-
Lansing, MichiganSparrow Clinical Research Institute
Apr 1, 2022
Oxytocin Deficiency, Hypopituitarism, Hypothalamic Obesity Trial in Barcelona (Melatonin)
Not yet recruiting
- Oxytocin Deficiency
- +5 more
- Melatonin
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Mar 31, 2022
Craniopharyngioma, Hypothalamic Obesity Trial in Philadelphia (Syntocinon, Placebo (for Syntocinon))
Active, not recruiting
- Craniopharyngioma
- Hypothalamic Obesity
- Syntocinon
- Placebo (for Syntocinon)
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 2, 2021
Craniopharyngioma, Hypothalamic Obesity, Metabolic Syndrome Trial in Vancouver (Hypothalamic Deep Brain Stimulation)
Withdrawn
- Craniopharyngioma
- +2 more
- Hypothalamic Deep Brain Stimulation
-
Vancouver, British Columbia, CanadaLeslie and Gordon Diamond Health Center
Oct 29, 2020
Craniopharyngiomas, Hypothalamic Obesity Trial in France (Exenatide, Placebo)
Completed
- Craniopharyngiomas
- Hypothalamic Obesity
- Exenatide
- Placebo
-
Angers, France
- +10 more
Oct 11, 2018
A Personalized Program of Physical Activity and Diet for
Completed
- Hypothalamic Obesity
- (no location specified)
Sep 14, 2018
Hypothalamic Obesity, Diabetes Trial in Shanghai (Exenatide)
Unknown status
- Hypothalamic Obesity
- Diabetes Mellitus
-
Shanghai, Shanghai, ChinaDepartment of Endocrinology and Metabolism
Oct 20, 2013